Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013

Parkinsonism & Related Disorders
Vincent LowCarl E Clarke

Abstract

Patients with Parkinson's disease have higher hospital admission rates than the general population. We examined the reasons for admission, length of stay, costs, and in-hospital mortality in a national sample of Parkinson's disease patients. We used hospital admission data from the English Hospital Episodes Statistics database (2009-2013). Patients with Parkinson's disease or Parkinson's disease dementia and aged over 35 years were compared to all other admissions, excluding the above, with the same age criteria. We examined reasons for admissions (ICD-10), length of stay and in-hospital mortality. We used indirect standardisation and Poisson modelling to derive proportional ratios adjusting for age group and sex. There were 324,055 Parkinson's disease admissions in 182,859 patients over 4 years which included 232,905 non-elective admissions (72%). This resulted in expenditure of £907 million (£777 million for non-elective admissions). The main reasons for admission were pneumonia (13.5%), motor decline (9.4%), urinary tract infection (9.2%), and hip fractures (4.3%). These conditions occurred 1.5 to 2.6 times more frequently in patients than controls. Patients with Parkinson's disease were almost twice as likely to stay in hos...Continue Reading

References

Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Mark GuttmanC David Naylor
Jun 18, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·M M WickremaratchiY Ben-Shlomo
Jul 25, 2009·Age and Ageing·Kalyani SnellRichard Walker
Sep 12, 2009·Acta Neurologica Scandinavica·C VossiusJ P Larsen
Sep 19, 2009·Journal of Neural Transmission·Colin KleinJose Martin Rabey
Jul 29, 2011·Journal of Public Health·E M BurnsO D Faiz
Nov 8, 2012·Age and Ageing·Frederiek van den BosHarald J J Verhaar
May 31, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Michal LubomskiStephen Tisch

❮ Previous
Next ❯

Citations

Oct 30, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Carmen Rodríguez-BlázquezPablo Martínez-Martín
Jun 1, 2016·Frontiers in Neurology·Nir GiladiAvi Orr-Urtreger
Jul 13, 2016·Journal of Neurochemistry·Sigurlaug Sveinbjornsdottir
Oct 21, 2016·Journal of the American Geriatrics Society·Petteri SjögrenMaude Wikström
Nov 30, 2016·Journal of Palliative Medicine·Ying LiuBenzi M Kluger
Jan 28, 2017·Journal of Medical Economics·Clement FrançoisAmy Duhig
Mar 16, 2016·PloS One·Ruth Gil-PrietoAngel Gil-de-Miguel
Apr 19, 2017·Parkinsonism & Related Disorders·Ugo Fedeli, Elena Schievano
Nov 27, 2016·Parkinsonism & Related Disorders·Hind A BeydounShaker M Eid
Jan 10, 2017·Parkinsonism & Related Disorders·Unax LertxundiJuan Carlos García-Moncó
Oct 28, 2017·CNS Drugs·Cyndya A Shibao, Horacio Kaufmann
Apr 9, 2015·British Journal of Hospital Medicine·Ros Levenson
May 31, 2019·Journal of Geriatric Psychiatry and Neurology·Sabina VatterIracema Leroi
Sep 27, 2019·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Stanley John WinserGladys Cheing
Sep 29, 2017·Neurology·Caroline MoreauDavid Devos
Jul 14, 2018·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·JoJo Yan Yan KwokHelen Yue Lai Chan
Oct 31, 2018·Health Technology Assessment : HTA·Doreen McClurgHelen Mason
Jul 20, 2019·Therapeutic Advances in Neurological Disorders·Iracema LeroiSheree A McCormick
Apr 6, 2019·Movement Disorders Clinical Practice·Clément FrançoisSteven M Kymes
Mar 28, 2019·Frontiers in Neurology·Jenny T van der SteenRaymond T C M Koopmans
Oct 20, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Sergio I PradaYuri Takeuchi
Oct 25, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L McMahonO Lennon
Jun 7, 2020·Journal of the Neurological Sciences·Jun Hee WonHan Gil Seo
Apr 2, 2021·Journal of Neurology, Neurosurgery, and Psychiatry·Umer AkbarBenzi Kluger
Apr 13, 2021·Journal of Parkinson's Disease·Diego Santos GarcíaUNKNOWN COPPADIS Study Group
May 11, 2021·Neurodegenerative Disease Management·Adrian I EspirituRoland Dominic G Jamora
Jul 6, 2021·Drugs & Aging·Veit MyliusSantiago Perez Lloret
Jul 29, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ekawat VichayanratJalesh N Panicker
Aug 20, 2021·Frontiers in Neurology·Anna-Christin WillertAlexander B Kowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Psychiatry
C G LyketsosP V Rabins
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
R L KalishL I Iezzoni
© 2022 Meta ULC. All rights reserved